on VALBIOTIS (EPA:ALVAL)
Valbiotis Enters Middle East Market with Exclusive Distribution Deal
Valbiotis, a French laboratory specializing in scientifically tested dietary supplements, announced an exclusive distribution agreement with Mena Nutrition for the Middle East. Mena Nutrition will market Valbiotis products in Saudi Arabia, Lebanon, and Iraq, with first revenues anticipated by late 2026.
Mena Nutrition, based in the UAE, boasts over 20 years of experience and a strong local presence. This strategic partnership aims to position ValbiotisPRO® products as the gold standard in cardiometabolic prevention, leveraging robust scientific support.
Commercialization is slated to begin after necessary health authority registrations are secured in each country. The Middle East markets hold significant potential for Valbiotis due to high prevalence rates of metabolic-related diseases.
This deal marks a key step in Valbiotis' international expansion strategy, emphasizing their commitment to preventive health solutions globally.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all VALBIOTIS news